I guess the trouble with omomyc or imyc was not so much the difficulty gettingvto clinic but the cost. Peptomyc had the rights to omomyc and we had the rights to imyc so hard to see any third party funding that to trials unless we totally sign over the rights first?? I guess peptomyc in similar position as plenty of grants and encouragement but i dont think any commercial offers yet. Although i believe we have talked to Ms Soucek i guess even if we team up the two groups together still could not fund myc trials required? Sad really as it seemed so promising and i feel cancer touches so many more of us than current targets, although for those affected by current targets this will still be wonderfull. Hopefully the reason current major holders were happy ti stump up more at market price is because we have some serious interest now and have been toldxwhat we need to demonstrate to open the bank doors??
PYC Price at posting:
3.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)